Predicate |
Object |
contentType |
Lecture|Research Support, N.I.H., Extramural |
endingPage |
575 |
issn |
1520-4804 0022-2623 |
issueIdentifier |
2 |
pageRange |
567-575 |
publicationName |
Journal of Medicinal Chemistry |
startingPage |
567 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d |
isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_58254fb77af952e93fdccca16c84806d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_724a2e51c4b2e36f44083174d633515f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b6f37332363e674484075a31f5649b1a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2e9f12711ddb17e73b57bec970f5592f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ef5dea2570da00f8eec5bce115aacc73 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fb92e6f1b1a894920977fe8d4b1ee1f0 |
bibliographicCitation |
Silverman RB. The 2011 E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances: (1S,3S)-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a GABA Aminotransferase Inactivator and New Treatment for Drug Addiction and Infantile Spasms. J. Med. Chem. 2012 Jan 10;55(2):567–75. doi: 10.1021/jm201650r. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a417e305f75c3183eac02a3af16e2d5 |
date |
2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/22168767 https://doi.org/10.1021/jm201650r https://pubmed.ncbi.nlm.nih.gov/PMC3266980 |
isPartOf |
https://portal.issn.org/resource/ISSN/0022-2623 https://portal.issn.org/resource/ISSN/1520-4804 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4938 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
The 2011 E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances: (1S,3S)-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a GABA Aminotransferase Inactivator and New Treatment for Drug Addiction and Infantile Spasms |
discusses |
http://id.nlm.nih.gov/mesh/M0328364 http://id.nlm.nih.gov/mesh/M0509806 http://id.nlm.nih.gov/mesh/M0000939 http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0017693 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D019966Q000188 http://id.nlm.nih.gov/mesh/D001363 http://id.nlm.nih.gov/mesh/D013036Q000188 http://id.nlm.nih.gov/mesh/D000612Q000037 http://id.nlm.nih.gov/mesh/D000927Q000494 http://id.nlm.nih.gov/mesh/D011392Q000031 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D019970Q000188 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D008958 http://id.nlm.nih.gov/mesh/D020888Q000627 http://id.nlm.nih.gov/mesh/D020888Q000737 http://id.nlm.nih.gov/mesh/D020888Q000494 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D015394 http://id.nlm.nih.gov/mesh/D000927Q000627 http://id.nlm.nih.gov/mesh/D011392Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000927Q000737 http://id.nlm.nih.gov/mesh/D011392Q000494 http://id.nlm.nih.gov/mesh/D011392Q000737 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10420 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9263 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71252718 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7bfb8034e39afae9e9f2b809bb4880d9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9794014 |